In COPD patients, increased autophagy activity in lung tissue is driven by Egr-1 in response to cigarette smoke, suggesting that Egr-1 may serve as a novel therapeutic target for treating cigarette-induced lung injury. This evidence concerns the gene EGR1 and chronic obstructive pulmonary disease.